The rituals of ancient Greece – especially public performances of tragic plays – have remarkable resonance with the current moment.
Academic rigour, journalistic flair
Articles on Coronavirus
Displaying 901 - 920 of 5483 articles
Australia’s current dilemma is that it has achieved local elimination but it is stumbling in the vital follow-up — rapid mass vaccination and quarantine centres.
Low levels of immunity and high levels of mixing are a perfect setting for the next big outbreak.
Sixteen countries authorised the use of Russia’s Sputnik V vaccine before phase 3 clinical trial results were published.
COVID-19 vaccine passports are being presented as a relatively simple technological solution to our current travel woes. But meaningful public debate about their merits and problems is essential.
A divide is growing between workers and management over the return to the office and other issues.
Offering incentives to encourage good health behavior isn’t new, but it does raise concerns. A behavioral scientist explains how rewarding those taking a shot need not keep ethicists up at night.
What does the Seychelles experience tell us about variants, vaccine efficacy and herd immunity?
While the pandemic has focused the world’s attention on how to prevent infectious disease, many of the lessons learned from COVID-19 prevention can also be applied to chronic disease prevention.
Teens have acutely felt the effects of the pandemic lockdowns on their social lives. As the end of stay-at-home orders draws nearer, it’s important to consider teenagers’ social and emotional needs.
The pandemic’s not over yet, but these world leaders have already cemented their place in history for failing to effectively combat the deadly coronavirus. Some of them didn’t even really try.
A public health expert outlines what Britons can expect from their upcoming booster programme.
It’s feasible to bring home at least some of the COVID-positive Australians stranded in India. Here’s how we can do it while keeping infection risk at a minimum.
While the results are very promising, it has only been tested in mice. Human clinical trials will take some time to complete before we know whether a drug could become available.
The United States and Canada have approved the Pfizer vaccine for adolescents aged 12–15. The evidence so far tells us it works well and is safe for this age group.
The mental health crisis occurring in tandem with COVID-19 has stressed resources and stretched service waitlists into years. There is an urgent need for prevention strategies, not just treatment.
Governments and companies are using incentives in hopes of getting more Americans to get a COVID-19 shot. A behavioral economist explains how they work.
Research has shown that vaccines have reduced infections, disease and hospitalisations – but will they continue to do so in the face of new variants?
Reports of fully vaccinated people getting infected with coronavirus shouldn’t cause alarm.
National procedures for approving the financing of the European recovery plan are delaying its implementation. But the horizon seems to be clearing.
Job Board
-
Assistant Editor - 1 year cadetship
-
Program Development Officer - Business Processes
-
Executive Dean, Faculty of Health
-
Lecturer/Senior Lecturer, Earth System Science (School of Science)
-
Sydney Horizon Educators (Identified)
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Associate Professor of Bioethics, University of Portsmouth
-
Associate Professor, Director Cabrini Monash University Department of Nursing Research, Monash University
-
Professor of Public Health, University of Sheffield
-
Professor of Medicine, University of East Anglia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Professor of Mathematics and Statistics, University of Strathclyde
